We are proud to announce our participation in RecoverAI, an ambitious research initiative that aims to explore innovative approaches to post-hospital care through the integration of advanced artificial intelligence and human expertise.
The project explores how Symbiotic Artificial Intelligence and Large Language Model (LLM)-based systems can provide continuous and personalized support to patients and caregivers following hospital discharge. Rather than replacing human decision-making, Symbiotic AI is designed to work alongside people, enhancing their capabilities, facilitating access to information, and supporting decisions throughout the recovery journey. The ultimate goal is to improve support recovery and continuity of care, increase quality of care, and reduce pressure on healthcare systems. Within RecoverAI, CoeLux will contribute its expertise in the effects of natural light on human wellbeing to investigate the potential role of home-based light exposure solutions designed to support wellbeing and convalescence during the post-discharge phase. The research will focus also on developing and testing innovative lighting solutions that can be integrated into the project's broader digital health ecosystem.
RecoverAI has been selected for funding through Collabora & Innova, a competitive innovation programme promoted by Regione Lombardia, one of Europe's leading industrial and research regions. Supported by the European Regional Development Fund (ERDF) 2021–2027, the initiative invests in collaborative research projects capable of generating significant social and technological impact. The project brings together a unique ecosystem of Lombardy-based organizations, including Exprivia, Purelab, the European Institute of Oncology (IEO), IRCCS Istituto Auxologico Italiano, the University of Bergamo, the University of Insubria, and CoeLux. We are grateful to all partners for the opportunity to combine diverse expertise and perspectives around a shared vision of healthcare innovation.
What makes RecoverAI particularly inspiring is its strongly interdisciplinary nature. By bringing together clinicians, researchers, technologists, designers, and industry innovators, the project embraces the very principles of Symbiotic AI: meaningful collaboration between different forms of intelligence, where people remain at the centre and technology becomes an enabler of better outcomes.
June 2026
